search
Back to results

Enhancing Function Using the RF Microstimulator Gait System Following Stroke 2008

Primary Purpose

Stroke

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
radio frequency-controlled (RF) Microstimulator (RFM) Gait System
Sponsored by
US Department of Veterans Affairs
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring Functional Electrical Stimulation

Eligibility Criteria

21 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Sufficient endurance to participate in rehabilitation sessions.
  • Medically Stable
  • Age >21 years.
  • Inability to perform normal ankle coordinated gait components.
  • Participants should be able to walk and keep balance without physical assistance from another person

Exclusion Criteria:

  • Acute or progressive cardiac, renal, respiratory, neurological disorders or malignancy.
  • Lower motor neuron damage or radiculopathy
  • Allergy or contraindication to anesthesia, Versed, (or comparable substitute.
  • Active implantable device (e.g. pacemaker, implantable cardiac defibrillator, neurostimulator, or drug infusion device.
  • Pregnancy

Sites / Locations

  • VA Medical Center, Cleveland

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Arm 1

Arm Description

radio frequency-controlled (RF) Microstimulator (RFM) Gait System

Outcomes

Primary Outcome Measures

Walking Endurance (6MWT)
The Six Minute Walk Test (6MWT) is a measure of the distance measured in feet ambulated by the participant during six minutes. A further distance walked in 6 minutes indicates improvement on the measure.
Kinematic Gait Measures
assessment of the lower limb kinematics during ambulation at chosen speed.

Secondary Outcome Measures

Fugl-Meyer Lower Extremity Score
Fugl-Meyer Lower Extremity Score (FMLE) is an itemized measure of lower extremity coordination following stroke. Scores for the FMLE range from 0 (most impaired) to 34 (normal).
Ashworth Scale
The Ashworth Scale is a measure of muscle spasticity; muscle groups are graded from 0 (no spasticity) to 4 (greatest spasticity/contracture). The lower limb muscle groups are summed for a total lower limb Ashworth score. A lower score indicates better performance. (range is 0-40)
Stroke Impact Scale (SIS)
The SIS is a measure of Quality of Life/Life Role Participation following stroke. Each item in a domain is scored between 0 and 5. A higher score indicates better performance (range 0-295).
Manual Muscle Testing (MMT)
This is a measure of strength of the various muscle groups of the lower limb. Each is graded on a 0 to 5 scale; the final score is the summed total of the lower limb muscle groups tested. (score range of summed muscles is 0-50, with 50 being the maximum highest score)

Full Information

First Posted
March 17, 2009
Last Updated
May 7, 2014
Sponsor
US Department of Veterans Affairs
Collaborators
The Alfred E. Mann Foundation for Scientific Research
search

1. Study Identification

Unique Protocol Identification Number
NCT00864708
Brief Title
Enhancing Function Using the RF Microstimulator Gait System Following Stroke 2008
Official Title
Enhancing Function Using the RF Microstimulator Gait System Following Stroke 2008
Study Type
Interventional

2. Study Status

Record Verification Date
May 2014
Overall Recruitment Status
Terminated
Why Stopped
The enrollment period/study duration had exceeded The Alfred Mann Foundation's timeline.
Study Start Date
December 2008 (undefined)
Primary Completion Date
April 2010 (Actual)
Study Completion Date
April 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
US Department of Veterans Affairs
Collaborators
The Alfred E. Mann Foundation for Scientific Research

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of the study is to investigate new Technology for recovery of ankle walking function after stroke.
Detailed Description
Background and Purpose: Conventional rehabilitation does not restore normal, upper limb function or normal gait to many stroke survivors. Functional neuromuscular stimulation (FNS) has shown promise for functional enhancement of both upper and lower limb motor control following stroke. Gains included muscle activation latencies, strength, coordination, upper limb functional tasks, gait kinematics, walking endurance, and quality of life. The purpose of the proposed work is to test the radio frequency-controlled (RF) Microstimulator (RFM) Gait System regarding system performance and subject response to treatment. Methods: This is a feasibility study in which up to four subjects will receive the (RFM) Gait System. Up to ten RFMs will be placed for a given subject. An RFM ankle muscle system will be used to train ankle gait components. A separate RFM system will be used to train knee gait components. Subjects will be treated for 6 months, four sessions/wk. Primary outcome measures for the RFM Gait System will be: kinematic swing phase gait components and walking endurance. Secondary outcome measures will include: strength, coordination, spasticity, function, and quality of life. Data collections will occur at months 1, 3 and 6, and for follow-up times up to a year after the end of treatment. The results of the RFM ankle system have the potential to provide a new technology for ankle muscle gait components.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
Functional Electrical Stimulation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
1 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Arm 1
Arm Type
Experimental
Arm Description
radio frequency-controlled (RF) Microstimulator (RFM) Gait System
Intervention Type
Device
Intervention Name(s)
radio frequency-controlled (RF) Microstimulator (RFM) Gait System
Intervention Description
Fully Implanted FES system to assist patient with gait component practice
Primary Outcome Measure Information:
Title
Walking Endurance (6MWT)
Description
The Six Minute Walk Test (6MWT) is a measure of the distance measured in feet ambulated by the participant during six minutes. A further distance walked in 6 minutes indicates improvement on the measure.
Time Frame
Day 1 and at 3 months, following treatment
Title
Kinematic Gait Measures
Description
assessment of the lower limb kinematics during ambulation at chosen speed.
Time Frame
Day 1 and at 3 months, following treatment
Secondary Outcome Measure Information:
Title
Fugl-Meyer Lower Extremity Score
Description
Fugl-Meyer Lower Extremity Score (FMLE) is an itemized measure of lower extremity coordination following stroke. Scores for the FMLE range from 0 (most impaired) to 34 (normal).
Time Frame
Day 1 and at 3 months, following treatment
Title
Ashworth Scale
Description
The Ashworth Scale is a measure of muscle spasticity; muscle groups are graded from 0 (no spasticity) to 4 (greatest spasticity/contracture). The lower limb muscle groups are summed for a total lower limb Ashworth score. A lower score indicates better performance. (range is 0-40)
Time Frame
Day 1 and at 3 months, following treatment
Title
Stroke Impact Scale (SIS)
Description
The SIS is a measure of Quality of Life/Life Role Participation following stroke. Each item in a domain is scored between 0 and 5. A higher score indicates better performance (range 0-295).
Time Frame
Day 1 and at 3 months, following treatment
Title
Manual Muscle Testing (MMT)
Description
This is a measure of strength of the various muscle groups of the lower limb. Each is graded on a 0 to 5 scale; the final score is the summed total of the lower limb muscle groups tested. (score range of summed muscles is 0-50, with 50 being the maximum highest score)
Time Frame
Day 1 and at 3 months, following treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Sufficient endurance to participate in rehabilitation sessions. Medically Stable Age >21 years. Inability to perform normal ankle coordinated gait components. Participants should be able to walk and keep balance without physical assistance from another person Exclusion Criteria: Acute or progressive cardiac, renal, respiratory, neurological disorders or malignancy. Lower motor neuron damage or radiculopathy Allergy or contraindication to anesthesia, Versed, (or comparable substitute. Active implantable device (e.g. pacemaker, implantable cardiac defibrillator, neurostimulator, or drug infusion device. Pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Janis Daly, PhD MS
Organizational Affiliation
VA Medical Center, Cleveland
Official's Role
Principal Investigator
Facility Information:
Facility Name
VA Medical Center, Cleveland
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44106
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Enhancing Function Using the RF Microstimulator Gait System Following Stroke 2008

We'll reach out to this number within 24 hrs